Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does adjunctive glaucoma therapy affect adherence to the initial primary therapy?

Alan L Robin1, David Covert

  • 1Bloomberg School of Public Health and the Wilmer Institute of Johns Hopkins School of Medicine, Baltimore, Maryland, USA. glaucomaexpert@cs.com

Ophthalmology
|May 10, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Remote Tonometry Identifies Significant Variability in the Timing of Intraocular Pressure Response to Topical Medication Change.

Ophthalmology. Glaucoma·2026
Same author

Long-term outcomes of Aurolab aqueous drainage implant in adults with refractory glaucoma.

The British journal of ophthalmology·2026
Same author

Efficacy of an Automated Point-of-Care Ultraviolet C Disinfection System for Reusable Ophthalmic Devices.

Ophthalmology·2026
Same author

Real-world efficacy, safety, and usability of a microvolume eyedrop delivery device in glaucoma: prospective randomized crossover trial.

Journal of cataract and refractive surgery·2025
Same author

Surgical Hand Antisepsis: How Can We Save Water?

American journal of ophthalmology·2025
Same author

Long-Term Follow-Up on a Juvenile Open-Angle Glaucoma Pedigree with a Novel EFEMP1 Mutation (c.1313, p.Tyr438Cys).

Ophthalmology. Glaucoma·2025
Same journal

Metastasis of Nasopharyngeal Squamous Cell Carcinoma to the Angle.

Ophthalmology·2026
Same journal

Endocrine Mucin-Producing Sweat Gland Carcinoma of Eyelid.

Ophthalmology·2026
Same journal

Multimodal Imaging of Optic Nerve Invasion in Unilateral Retinoblastoma.

Ophthalmology·2026
Same journal

Avacincaptad Pegol Slows Progressive Ellipsoid Zone Degradation/Loss in Eyes With Geographic Atrophy.

Ophthalmology·2026
Same journal

Access to Intravitreal Anti-VEGF Drugs in Persons with Medicare Advantage Compared with Medicare Fee-For-Service.

Ophthalmology·2026
Same journal

Re: Dones et al.: Emergency department use of ocular point-of-care ultrasound and its utility in diagnosis at a tertiary academic medical center (Ophthalmology. 2026;133:720-727).

Ophthalmology·2026
See all related articles

Adding a second glaucoma medication to a once-daily regimen increased refill intervals for the initial drug, potentially impacting adherence and intraocular pressure control. Physicians should consider this effect when prescribing complex treatment plans.

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Health Services Research

Background:

  • Glaucoma management often involves multiple ocular hypotensive medications.
  • Patient adherence to complex medication regimens can be challenging.
  • Understanding refill patterns provides insight into medication adherence.

Purpose of the Study:

  • To evaluate the impact of adding a second medication on the refill rate of a once-daily glaucoma drug.
  • To infer potential changes in patient adherence with increased treatment complexity.

Main Methods:

  • Retrospective review of patient records from a large national healthcare provider.
  • Analysis of refill intervals for latanoprost before and after the addition of a second ocular hypotensive medication.
  • Comparison of refill patterns between patients on monotherapy and those on dual therapy.

Related Experiment Videos

Main Results:

  • Patients receiving a second medication showed a statistically significant increase in the mean refill interval for their initial drug (latanoprost).
  • A notable percentage of patients (22.9%) experienced an increase in refill interval exceeding two weeks after adding a second medication.
  • The mean refill interval for patients on dual therapy was longer compared to those on latanoprost monotherapy.

Conclusions:

  • Increased refill intervals suggest potential alterations in patient adherence when treatment complexity increases.
  • The observed changes in refill patterns may have clinical implications for intraocular pressure control in glaucoma patients.
  • Physicians should consider the potential impact on adherence when initiating second-line therapy for glaucoma.